Sjællands Universitetshospital
- Address
- lock Available on a paid plan
Sjællands Universitetshospital - Rhinology and Airway Disease Research
Sjællands Universitetshospital is a leading academic medical center conducting innovative research in chronic respiratory and sinonasal conditions. The institution demonstrates particular expertise in investigating long-term outcomes and treatment optimization strategies for patients with complex airway diseases.
- Chronic rhinosinusitis with nasal polyps and biologic therapy outcomes
- Monoclonal antibody treatment protocols and remission strategies
- Long-term disease management and treatment discontinuation studies
The center's research program focuses on advancing personalized medicine approaches for chronic rhinosinusitis with nasal polyps, with particular emphasis on understanding whether patients treated with monoclonal antibody therapy can achieve sustained remission after treatment cessation. This work has important implications for optimizing therapeutic strategies, reducing long-term treatment burden, and improving quality of life for patients with chronic inflammatory airway conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Region Hovedstaden1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Region Hovedstaden2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 111 other sites in Denmark
Therapeutic Area Benchmark — Denmark
Select a therapeutic area to compare against other sites in Denmark.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Denmark
Market Share
Country: Denmark
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Sjællands Universitetshospital
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Biologic Tapering with Mepolizumab and Dupilumab in Patients with Severe Chronic Rhinosinusitis with Nasal Polyps: A Danish RCT | Region Hovedstaden | Phase III | Recruiting | May 2025 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dupilumab | 2 | Unknown | 2025-04-03 | 2025-05-27 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.